• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素及选择性雌激素受体调节剂在子宫内膜癌发生中的分子机制

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.

作者信息

Shang Yongfeng

机构信息

Department of Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100083, China.

出版信息

Nat Rev Cancer. 2006 May;6(5):360-8. doi: 10.1038/nrc1879.

DOI:10.1038/nrc1879
PMID:16633364
Abstract

Endometrial cancer is the most common gynaecological cancer, and is associated with endometrial hyperplasia, unopposed oestrogen exposure and adjuvant therapy for breast cancer using selective oestrogen-receptor modulators (SERMs), particularly tamoxifen. Oestrogen and SERMs are thought to be involved in endometrial carcinogenesis through their effects on transcriptional regulation. Ultimately, oestrogen and SERMs affect the transduction of cellular signalling pathways that govern cell growth and proliferation, through downstream effectors such as PAX2 (paired box 2).

摘要

子宫内膜癌是最常见的妇科癌症,与子宫内膜增生、无对抗性雌激素暴露以及使用选择性雌激素受体调节剂(SERM)进行的乳腺癌辅助治疗有关,尤其是他莫昔芬。雌激素和SERM被认为通过其对转录调控的影响参与子宫内膜癌发生。最终,雌激素和SERM通过下游效应因子如PAX2(配对盒基因2)影响控制细胞生长和增殖的细胞信号通路的转导。

相似文献

1
Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.雌激素及选择性雌激素受体调节剂在子宫内膜癌发生中的分子机制
Nat Rev Cancer. 2006 May;6(5):360-8. doi: 10.1038/nrc1879.
2
Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis.PAX2的低甲基化相关激活介导他莫昔芬刺激的子宫内膜癌发生。
Nature. 2005 Dec 15;438(7070):981-7. doi: 10.1038/nature04225.
3
Hormones and cancer.激素与癌症。
Cell Res. 2007 Apr;17(4):277-9. doi: 10.1038/cr.2007.26.
4
Extracellular matrix integrity: a possible mechanism for differential clinical effects among selective estrogen receptor modulators and estrogens?
Mol Cell Endocrinol. 2006 Mar 9;247(1-2):53-9. doi: 10.1016/j.mce.2005.12.020. Epub 2006 Jan 19.
5
Differential actions of estrogen and SERMs in regulation of the actin cytoskeleton of endometrial cells.雌激素和选择性雌激素受体调节剂在调节子宫内膜细胞肌动蛋白细胞骨架中的差异作用。
Mol Hum Reprod. 2009 Oct;15(10):675-85. doi: 10.1093/molehr/gap045. Epub 2009 Jun 18.
6
The endometrial effects of SERMs.选择性雌激素受体调节剂对子宫内膜的影响。
Hum Reprod Update. 2000 May-Jun;6(3):244-54. doi: 10.1093/humupd/6.3.244.
7
Oestrogen receptors and selective oestrogen receptor modulators: molecular and cellular pharmacology.雌激素受体与选择性雌激素受体调节剂:分子与细胞药理学
Basic Clin Pharmacol Toxicol. 2005 Jan;96(1):15-25. doi: 10.1111/j.1742-7843.2005.pto960103.x.
8
Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer.他莫昔芬治疗的乳腺癌女性中的雌激素受体多态性
Gynecol Endocrinol. 2006 Apr;22(4):185-9. doi: 10.1080/09513590600645767.
9
Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects.金属络合物选择性雌激素受体调节剂(SERMs)。不同金属单元对乳腺癌细胞抗增殖作用的影响。
Dalton Trans. 2006 Jan 28(4):529-41. doi: 10.1039/b509984f. Epub 2005 Sep 27.
10
Estrogens and SERMs in coronary heart disease.雌激素与选择性雌激素受体调节剂在冠心病中的作用
Curr Opin Pharmacol. 2007 Apr;7(2):130-9. doi: 10.1016/j.coph.2006.10.009. Epub 2007 Feb 20.

引用本文的文献

1
SIRT7 facilitates endometrial cancer progression by regulating PTEN stability in an estrogen-dependent manner.SIRT7通过以雌激素依赖的方式调节PTEN稳定性来促进子宫内膜癌进展。
Nat Commun. 2025 Mar 27;16(1):2989. doi: 10.1038/s41467-025-58317-0.
2
Significance of Gelsolin Superfamily Genes in Diagnosis, Prognosis and Immune Microenvironment Regulation for Endometrial Cancer.凝溶胶蛋白超家族基因在子宫内膜癌诊断、预后及免疫微环境调节中的意义
Cancer Med. 2025 Feb;14(4):e70584. doi: 10.1002/cam4.70584.
3
Computational Screening of Some Phytochemicals to Identify Best Modulators for Ligand Binding Domain of Estrogen Receptor Alpha.
某些植物化学物质的计算筛选,以确定雌激素受体α配体结合域的最佳调节剂。
Curr Pharm Des. 2024;30(20):1599-1609. doi: 10.2174/0113816128287431240408045732.
4
Genetic evidence for causal relationships between age at natural menopause and the risk of ageing-associated adverse health outcomes.遗传证据表明,自然绝经年龄与与衰老相关的不良健康结局风险之间存在因果关系。
Int J Epidemiol. 2023 Jun 6;52(3):806-816. doi: 10.1093/ije/dyac215.
5
Discovery of Highly Functionalized 5-hydroxy-2-pyrrol-2-ones That Exhibit Antiestrogenic Effects in Breast and Endometrial Cancer Cells and Potentiate the Antitumoral Effect of Tamoxifen.发现具有高度官能化的5-羟基-2-吡咯-2-酮,其在乳腺癌和子宫内膜癌细胞中表现出抗雌激素作用,并增强他莫昔芬的抗肿瘤作用。
Cancers (Basel). 2022 Oct 22;14(21):5174. doi: 10.3390/cancers14215174.
6
Role of estrogen receptors in health and disease.雌激素受体在健康和疾病中的作用。
Front Endocrinol (Lausanne). 2022 Aug 18;13:839005. doi: 10.3389/fendo.2022.839005. eCollection 2022.
7
Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic Prospects.肺癌中靶向核受体——新的治疗前景
Pharmaceuticals (Basel). 2022 May 18;15(5):624. doi: 10.3390/ph15050624.
8
Review of Mendelian Randomization Studies on Endometrial Cancer.子宫内膜癌的孟德尔随机化研究综述。
Front Endocrinol (Lausanne). 2022 May 9;13:783150. doi: 10.3389/fendo.2022.783150. eCollection 2022.
9
2',3',4'-Trihydroxychalcone changes estrogen receptor α regulation of genes and breast cancer cell proliferation by a reprogramming mechanism.2',3',4'-三羟基查耳酮通过重编程机制改变雌激素受体α对基因的调控及乳腺癌细胞的增殖。
Mol Med. 2022 Apr 25;28(1):44. doi: 10.1186/s10020-022-00470-z.
10
Estrogen Receptor Function: Impact on the Human Endometrium.雌激素受体功能:对人子宫内膜的影响。
Front Endocrinol (Lausanne). 2022 Feb 28;13:827724. doi: 10.3389/fendo.2022.827724. eCollection 2022.